Our findings suggest that initiating ART at the intermediate CD4 count of 500 cells/mm3, according to current guidelines, could by itself have a substantial impact on HIV incidence, reducing the expected number of new HIV infections by 8.5% over 20 years. This evidence concerns the gene CD4 and HIV infectious disease.